OncoFusion Therapeutics, Inc. — Form D
OncoFusion Therapeutics, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-01. The offering totals $750K, of which $525K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-03-01
- Form: D
- Accession: 0001570291-13-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $750K
- Amount sold: $525K
- Remaining: $225K
- Investors: 9
- Date of first sale: 2013-02-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-192602
Issuer
- Name: OncoFusion Therapeutics, Inc.
- CIK: 0001570291
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1600 HURON PARKWAY, ANN ARBOR, MI, 48109
- Phone: 734-615-0362
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mel Sorensen, M.D. | Director | Ann Arbor, MI |
| Shaomeng Wang | Director | Malvern, PA |
| Peter Sugar | Executive Officer | Southfield, MI |
| Shaomeng Wang | Executive Officer | Malvern, PA |
More